---
title: "Shuanglu Pharmaceutical's investee company CF PHARMTECH is expected to be listed on the Stock Exchange on October 8"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259447576.md"
description: "According to the announcement from Zhitong Finance APP, Shuanglu Pharmaceutical announced that its affiliated company CF PHARMTECH is expected to officially list on the Hong Kong Stock Exchange on October 8, 2025. According to the global offering prospectus of CF PHARMTECH, it will offer 41.198 million shares in this global offering, with a sale price of HKD 14.75 per share"
datetime: "2025-09-30T04:21:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259447576.md)
  - [en](https://longbridge.com/en/news/259447576.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259447576.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/259447576.md) | [繁體中文](https://longbridge.com/zh-HK/news/259447576.md)


# Shuanglu Pharmaceutical's investee company CF PHARMTECH is expected to be listed on the Stock Exchange on October 8

According to the announcement from Zhitong Finance APP, Shuanglu Pharmaceutical (002038.SZ) stated that its associate company CF PHARMTECH (02652) is expected to officially list on the Stock Exchange on October 8, 2025. According to the global offering prospectus of CF PHARMTECH, it will offer 41.198 million shares in this global offering, with a sale price of HKD 14.75 per share

### Related Stocks

- [CF PHARMTECH (02652.HK)](https://longbridge.com/en/quote/02652.HK.md)

## Related News & Research

- [CF Pharmtech Repurchases 10,500 Shares for HKD 370,460 in HKEX Filing](https://longbridge.com/en/news/275444806.md)
- [Cathay Pacific Lifts 2025 Profit as Capacity and Utilisation Surge](https://longbridge.com/en/news/278655299.md)
- [Private Advisor Group LLC Acquires 9,121 Shares of Coinbase Global, Inc. $COIN](https://longbridge.com/en/news/278701194.md)
- [HSBC Holdings Issues $8 Billion Worth of Notes](https://longbridge.com/en/news/278644892.md)
- [Huatai Securities Keeps Their Buy Rating on JD.com, Inc. Class A (9618)](https://longbridge.com/en/news/278664490.md)